Less Ads, More Data, More Tools Register for FREE

Pin to quick picksToyota Motor Regulatory News (TYT)

Share Price Information for Toyota Motor (TYT)

Share Price is delayed by 15 minutes
Get Live Data
2,804.30632    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap:
TYT Live PriceLast checked at - London Stock Exchange

Intraday Toyota Motor Share Chart

Stabilisation Notice

Today 09:49

RNS Number : 2155J
J.P. Morgan Securities PLC.
22 June 2026
 

22nd June 2026

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Toyota Motor Corporation

 

Pre-stabilisation Period Announcement

 

J.P. Morgan Securities PLC, (contact: Robert Chambers +442071342468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

Toyota Motor Corporation

Obligor (if any):

N/A

Aggregate nominal amount:

EUR 4yrFXD - 500M WNG

EUR 8yrFXD - 500M WNG

Description:

EUR RegS Registered Senior Unsecured FXD notes

 

Listing: Singapore Exchange Securities Trading Limited (SGX-ST)

Offer price:

TBC

Other offer terms:

EUR 100k x 1k

Stabilisation: Relevant Stabilisation regulation applies 

Stabilisation Manager(s):

J.P. Morgan Securities PLC (Stabilisation coordinator)

BOFA Securities (Stabilisation manager)

Morgan Stanley (Stabilisation manager)

Barclays (Stabilisation manager)

BNP Paribas (Stabilisation manager)

Stabilisation period expected to start on:

22nd June 2026

Stabilisation period expected to end no later than:

22nd July 2026

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAEAPKAALKKEEA
Date   Source Headline
11th Jan 20228:00 amRNSRepurchase of Shares of our Common Stock
23rd Dec 20218:00 amRNSCorporate Governance Report
15th Dec 20218:00 amRNSProduction Plans in January 2022
3rd Dec 20218:00 amRNSAnnounces Changes to Executive Structure
3rd Dec 20218:00 amRNSRepurchase of Shares of our Common Stock
30th Nov 20218:00 amRNSFinancial Statements(FY2022 Second Quarter)
30th Nov 20218:00 amRNSSummary of Quarterly Securities Report
12th Nov 20218:00 amRNSProduction Plans in December 2021
4th Nov 202112:00 pmRNSAmendment to Form 20-F for FY2016-2020
4th Nov 20218:00 amRNSFY2022 Second Quarter Financial Summary
4th Nov 20218:00 amRNSRepurchase of Shares of Common Stock
4th Nov 20218:00 amRNSDistribution of Interim Dividends from Surplus
15th Oct 20218:00 amRNSProduction Plans in November 2021
27th Sep 20218:00 amRNSStatus and Completion of the Repurchase of Shares
10th Sep 20218:00 amRNSChanges to Production Plans for September&October
3rd Sep 20218:00 amRNSRepurchase of shares of our common stock
31st Aug 20218:00 amRNSSummary of Quarterly Securities Report
31st Aug 20218:00 amRNSFinancial Statements (FY2022 First Quarter)
19th Aug 202111:09 amRNSAdjustments to Domestic Production
4th Aug 20218:00 amRNSFY2022 First Quarter Financial Summary
4th Aug 20218:00 amRNSRepurchase of shares of our common stock
21st Jul 20218:00 amRNSIsuzu and Daihatsu join CJP project
5th Jul 20218:00 amRNSRepurchase of shares of our common stock
24th Jun 202112:00 pmRNSCorporate Governance Report
24th Jun 202112:00 pmRNSSummary Securities Report
24th Jun 202112:00 pmRNSFY2021 Annual Report
17th Jun 20218:00 amRNSVoting Results of General Shareholders' Meeting
17th Jun 20218:00 amRNSResolutions Adopted at Shareholders’ Meeting
16th Jun 20218:00 amRNSDisposition of Treasury Stock under RS Plan
17th May 20218:00 amRNSNotice of Convocation
12th May 20218:00 amRNSPartial Amendments to Articles of Incorporation
12th May 20218:00 amRNSDistribution of Dividends from Surplus
12th May 20218:00 amRNSHolding of Ordinary General Shareholders’ Meeting
12th May 20218:00 amRNSFiling of Shelf Registration Statement
12th May 20218:00 amRNSCommon Stock Split
12th May 20218:00 amRNSRepurchase of Shares of Common Stock
12th May 20218:00 amRNSFY2021 Financial Summary
6th Apr 20217:00 amRNSCompletion of Acquisition and Cancellation
24th Mar 20218:00 amRNSCommercial vehicle partnership with Isuzu and Hino
24th Mar 20218:00 amRNSChanges in management
26th Feb 20218:00 amRNSFinancial Statements (FY2021 Third Quarter)
26th Feb 20218:00 amRNSSummary of Quarterly Securities Report
10th Feb 20218:00 amRNSThird Quarter Results
10th Feb 20218:00 amRNSAmendments to Forecasts for FY2021
14th Dec 20208:00 amRNSNotice concerning Acquisition and Cancellation
3rd Dec 20208:00 amRNSAnnouncement regarding the changes in management
30th Nov 20208:00 amRNSFinancial Statements (FY2021 Second Quarter)
30th Nov 20208:00 amRNSSummary of Quarterly Securities Report
6th Nov 20208:00 amRNSDistribution of Interim Dividends from Surplus
6th Nov 20208:00 amRNS2nd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.